Oxfordshire vaccine manufacturing site part of 10-year agreement between Moderna and UK government
In an effort to protect against potential future global health emergencies, the government of the UK and Moderna have cemented a 10-year partnership for vaccine manufacturing and research.
Pharmaceutical and biotech giant Moderna has struck a deal with the government of the UK that aims to bring a state-of-the-art vaccine manufacturing site to Harwell, Oxfordshire, among other partnership agreements.
The partnership will allow the establishment of a new Innovation and Technology Centre as part of a Harwell science campus, creating over 150 highly skilled jobs and increasing the UKs manufacturing capacity of up to 250 million vaccines per year for respiratory diseases such as flu, respiratory syncytial virus, and COVID-19. In a bid to protect the patients in the UK against potential future global health threats, NHS patients will also gain access to Moderna’s COVID-19 vaccine against several strains of the virus through rapid access to the latest developments in vaccine technology.
Chief Executive of the UK Health Security Agency Dr. Jenny Harries has commented that her department’s COVID Vaccine Unit has “played such a major role in bringing this exciting partnership with Modern to fruition. UKHSA will now be taking this forward as a vital part of our preparedness against future respiratory virus threats, including COVID-19.” She added, “Our scientists have been monitoring the evolution of the virus throughout the pandemic and assuring continued protection for the population. This partnership will take the winning ways of working with industry and build the nation’s resilience, giving us rapid access to vaccines. We look forward to working closely with Moderna and playing a key role in supporting the government’s ambitious life sciences strategy.”
The opportunity to develop vaccines within the UK has been credited with rapidly scaling production in the event of a health emergency and bolstering the nation’s potential responses to future pandemics. The UK was the first nation to administer a vaccine for COVID-19 outside of a clinical trial, a milestone the government hopes to continue with the construction of the vaccine manufacturing site: “It is vital we invest in fighting future variants of [COVID-19] as well as other deadly viruses that are circulating, such as seasonal flu and RSV, and this partnership with Moderna will also strengthen our ability to respond to any future pandemics. By boosting our onshore vaccine manufacturing capability, we are a step closer to becoming the leading global hub for life sciences,” stated Steve Barclay, Secretary of State for Health and Social Care.
Over a 10-year period, Moderna will work with the COVID Vaccine Unit, a part of the UKHSA, to invest in UK-based R&D activities such as running substantially more clinical trials in the UK and offering grant funding for those in PhD and research programmes at UK universities. Kicking off the success of mRNA technology adoption with the COVID-19 vaccine, the new Innovation and Technology Centre will allow for the development of similar revolutionary treatments in the UK, to the benefit of NHS patients and across the world. Since the agreement’s announcement in June 2022, construction is slated to commence early this year and by 2025, the first mRNA vaccine is expected to be produced in the UK.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance